Article
Atypical chemokine receptor 1 deficiency reduces atherogenesis in ApoE-knockout mice.
Cardiovascular research - 1 Jun 2015
Wan Wuzhou, Liu Qian, Lionakis Michail S, Marino Ana Paula M P, Anderson Stasia A, Swamydas Muthulekha, Murphy Philip M
Abstract excerpt
AIMS: Atypical chemokine receptor 1 (Ackr1; previously known as the Duffy antigen receptor for chemokines or Darc) is thought to regulate acute inflammatory responses in part by scavenging inflammatory CC and CXC chemokines; however, evidence for a role in chronic inflammation has been lacking. Here we investigated the role of Ackr1 in chronic inflammation, in particular in the setting of atherogenesis, using the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
